SecBot SecBot
144 ·Filed Oct 30, 2026

TAK

TAKEDA PHARMACEUTICAL CO LTD
NEUTRAL
Impact 2/10
Horizondays Processed17d 5h ago SEC0001493152-26-049487
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The filing is a standard advance notice for a planned insider sale tied to tax obligations on vested equity. No material impact expected; monitor for any acceleration of insider selling patterns or changes in executive holdings.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$20.87
T+0 close · Oct 30, 2026 · via day close
Latest settled
+1.05%
T+5 · $21.09 · next T+20 in 14d
Vs SPY
+0.98%
α at T+5
Latest observation
+4.16%
T+9 · FF3 residual α
  1. T+0 · Nov 2 $20.87entry
  2. T+1 · 14d ago −0.57%α −0.87% · $20.75
  3. T+5 · 8d ago +1.05%α +0.98% · $21.09
  4. T+10 · todayOpen
  5. T+20 · in 14d Pending
  6. T+60 · in 2mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Giles Richard Platford, President of Takeda's International Business Unit, filed a Form 144 notice of intent to sell 55,617 American Depositary Shares (ADSs) with an approximate market value of $1.12 million. The shares were acquired via vested restricted stock unit awards on July 30, 2024, and the sale is scheduled for or after November 1, 2026. The filing is a routine insider sale for tax-related purposes, representing a small fraction of the company's $63.7 billion market cap.

Key Facts

  • Insider Giles Richard Platford (President, International Business Unit) filed Form 144 to sell 55,617 ADSs.
  • Estimated aggregate market value of the proposed sale is approximately $1,121,794.89.
  • Shares were acquired via vested restricted stock unit awards on July 30, 2024, as compensation.
  • Proposed sale date is November 1, 2026.
  • A prior sale of 31,083 ADSs on August 10, 2026, was conducted to satisfy tax obligations related to share vesting.
  • The sale represents about 0.0018% of Takeda's $63.7B market cap.

Financial Impact

Proposed sale of 55,617 ADSs valued at ~$1.12 million, a negligible 0.0018% of market cap.

dilution

Risk Factors

  • Form 144 signals intent to sell, but the actual sale may not occur.
  • No additional context on company performance or upcoming catalysts provided in the filing.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
67% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001493152-26-049487
Document: 0001493152-26-049487-index.html0001493152-26-049487
Document: 0001493152-26-049487.txt0001493152-26-049487

Track record

18 reports on TAK

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $21.19 to $21.12 Now $21.59 +1.89% ▼ −0.33% −3.62% vs SPY
  2. Oct 30, 202617d ago 144 Neutral 2/10 Viewing Entry $20.87 to $21.09 Now $21.59 +3.45% ▲ +1.05% +0.98% vs SPY
  3. Oct 30, 202617d ago 144 Neutral 2/10 Entry $20.87 to $21.09 Now $21.59 +3.45% ▲ +1.05% +0.98% vs SPY
  4. Oct 29, 202618d ago 6-K Neutral 4/10 No price data
  5. Oct 29, 202618d ago 6-K Bearish 5/10 Entry $20.01 to $21.19 Now $21.59 −7.90% ▼ −5.90% −10.62% vs SPY
  6. Sep 14, 20269w ago 6-K Bullish 7/10 Entry $18.60 to $18.89 Now $21.59 +16.08% ▲ +1.56% +1.45% vs SPY
  7. Aug 21, 202612w ago Insider Cluster Neutral 2/10 Entry $18.24 to $17.98 Now $21.59 +18.37% ▼ −1.43% −1.89% vs SPY
  8. Aug 19, 202612w ago Insider Cluster Neutral 2/10 Entry $18.13 to $18.03 Now $21.59 +19.08% ▼ −0.55% −1.67% vs SPY
  9. Aug 14, 202613w ago Court Ruling Neutral 4/10 Entry $17.38 to $18.24 Now $21.59 +24.22% ▲ +4.95% +6.14% vs SPY
  10. Aug 12, 202613w ago Insider Cluster Neutral 3/10 Entry $17.39 to $18.13 Now $21.59 +24.15% ▲ +4.26% +6.22% vs SPY
Showing 10 of 18

US Market Status

Market Closed · Opens Wed (10h 2m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 30, 2026